Completed trials

Host Defence Peptides

Technology

Completed trials

Posters

Publications

Pipeline

Completed clincal trials:

  • A first in man Phase I study to investigate tolerability and safety of topical LTX-109 in healthy subjects (Study C08-109-01)

Impetigo

Nasal Decolonization

Overview of completed studies

Study